Cnib
CNIB is a registered charity, passionately providing community-based support, knowledge and a national voice to ensure Canadians who are blind or partially sighted have the confidence, skills and opportunities to fully participate in life. INCA est un organisme de bienfaisance enregistr_ qui fournit avec ferveur un soutien communautaire, des renseignements et une repr_sentation nationale aux Canadiens aveugles ou ayant une vision partielle afin de s'assurer qu'ils ont la confiance en soi, les comp_tences et la possibilit_ de se r_aliser pleinement dans la soci_t_.
Nonprofit Organization Management
East York, Ontario, Canada
About

CNIB is a registered charity, passionately providing community-based support, knowledge and a national voice to ensure Canadians who are blind or partially sighted have the confidence, skills and opportunities to fully participate in life.

INCA est un organisme de bienfaisance enregistr_ qui fournit avec ferveur un soutien communautaire, des renseignements et une repr_sentation nationale aux Canadiens aveugles ou ayant une vision partielle afin de s'assurer qu'ils ont la confiance en soi, les comp_tences et la possibilit_ de se r_aliser pleinement dans la soci_t_.

Site Traffic
  • 414809 Global Rank
  • 16903
    Canada
  • 117 K Estimated Visits
Traffic Sources
  • Search
    55.89%
  • Direct
    37.52%
  • Social
    4.59%
  • Referrals
    2.00%
  • Display
    0.00%
  • Mail
    0.00%
Geography Breakdown
Powered by
Alexa Traffic Data
Global Rank 444,681
1,025,186
United States Rank 164,876
96,733
United States Page Views 53.8%
19.6%
Top Countries
Top Search Keywords
  • Eye Disorders
  • Blindness
Mobile App Data
MixRank is the most comprehensive database of mobile apps, developers, SDKs, technologies, services, and integrations. Learn more.
  • 1 SDKs
  • 3.4 Avg. Rating
  • 6 Total reviews
  • App Url: https://itunes.apple.com/app/cnib/id521037459
  • App Support: http://www.cnib.ca
  • Genre: Medical
  • Bundle ID: ca.cnib.iSimulator
  • App Size: 4.89 M
  • Version: 1.2
  • Release Date: April 30th, 2012
  • Update Date: April 26th, 2013

Description:

See how eye disease can change your point of view with CNIB’s iSimulator iPhone app.

Use your phone’s built-in camera to take photos that show how the most common eye diseases in Canada – age-related macular degeneration, glaucoma, diabetic retinopathy and cataracts – can affect your vision. Using the app, you can adjust the intensity of the selected eye disease to reflect the progression of vision loss a person may experience.

The iSimulator makes it easy for you to save and share your photo through email, Facebook or even Twitter. You can also access a wide range of online information about each eye condition through the app, including CNIB’s comprehensive Eye Connect resource.

For more information, please visit www.cnib.ca. The iSimulator has been made possible with the support of an educational grant from Novartis Pharmaceuticals Canada Inc.: www.novartis.ca

Voyez comment la maladie oculaire peut changer votre façon de voir les choses grâce à l’application SimulVision INCA. 

Utilisez la caméra de votre téléphone pour prendre des photos qui vous montreront comment les maladies oculaires les plus fréquentes au Canada — la dégénérescence maculaire liée à l’âge, le glaucome, la rétinopathie diabétique et les cataractes — peuvent modifier votre vision. Lorsque vous utilisez cette application, vous pouvez augmenter la gravité de la maladie oculaire choisie pour constater la progression de la perte de vision que pourrait subir la personne atteinte.

L’application SimulVision INCA vous permet de sauvegarder votre photo, de la transmettre facilement par courriel, ou de la partager sur Facebook ou même Twitter. Cette application vous donne aussi accès à une foule de renseignements sur chacune des maladies oculaires présentées et notamment au très complet Point de vue INCA.

Pour en savoir plus à ce sujet, visitez www.inca.ca. L’application SimulVision INCA a été rendue possible grâce à une subvention à des fins éducatives de Novartis Pharma Canada inc. : www.novartis.ca/index-fr.shtml

Sort by

60+Boss60+

Mar 15, 2016

Boring

Booooo not enough information on the eyes of eye balls

Supermom8303

Mar 03, 2015

Was amazing! Doesn't work with iPhone 6

I work with individuals who are legally blind this app assists their families in understanding. It no longer works with the new iOS system 👎👎. Was an amazing app PLEASE UPDATE

Apr 23, 2014

Only 4 eye diseases in the world???

There are only 4 diseases here. What about retinitis pigmentosa and the rest of the other eye diseases?? This app is counter productive for awareness and understanding. I'm unimpressed and feel alienated by this. Please do something about this

May 10, 2012

Fantastique !!

Très intéressant de voir ce que ces patho peuvent signifier!

May 07, 2012

iSimulator from CNIB

Great app! Really helps people understand what these common eye conditions are like. If you have a friend or relative with any of these, it will definitely be of benefit.

Apr 30, 2012

Great App!

After using the eye simulator I now realize how much I take 20-20 vision for granted.
Facebook
The iOS SDK provides Facebook Platform support for iOS apps
Data sourced from MixRank, the most comprehensive database of mobile apps, developers, SDKs, technologies, services, and integrations. Learn More.
Ad Intelligence
  • Standard
    100.00%
Ads Seen Recently
5
Longest Running Ad
Cnib
Device
Desktop
Dimensions
other
Cnib
Device
Desktop
Dimensions
other
Cnib
Device
Desktop
Dimensions
300x600
Cnib
Device
Desktop
Dimensions
300x250
Cnib
Device
Desktop
Dimensions
728x90
Cnib
Device
Desktop
Dimensions
728x90
Cnib receives up to 0.04M pageviews per day.

They are headquartered at East York, Ontario, Canada, and have 1 advertising & marketing contacts listed on Kochava. Cnib works with Advertising technology companies such as Google Adsense, Blue Lithium, Yield Manager, Yahoo Publisher Network, DoubleClick.Net, Facebook Custom Audiences, Google Remarketing, DoubleClick Bid Manager, AppNexus, Rubicon Project, Microsoft Advertising.